The investment focus of LuxTopic - Aktien Europa is on shares of major European companies. These organisations generate their revenues not only in Europe but also in the high-growth regions of the world. They have sound assets and high earning power. A technical selection process is used to choose individual stocks from the universe of European blue chips. The active risk management is also used to limit the negative effect of market downturns. In addition to equities, it can also invest in fixed and variable-rate securities.
Responsible manager since inception
|Category:||Equity Funds - European Blue Chips|
|VG/KVG:||DJE Investment S.A.|
|Fund Manager:||Robert Beer Management GmbH|
|Type of Share:||distribution|
|Financial Year:||01.01. - 31.12.|
|Fund Size (19/01/2021):||119,34 Mio EUR|
|TER p.a. (30/12/2019):||2,20 %|
|Reference Index:||100% Euro Stoxx 50|
|Initial Charge:||5,00 %|
|Management Fee p.a.:||1,76 %|
|Custodian Fee p.a.:||0,09 %|
|Advisory Fee p.a.:||1,00 %|
Ratings & Awards (19/01/2021)
Performance in Percent vs. Reference Index
Top Country Allocation (30/12/2020)
|United Kingdom||3,31 %|
Asset Allocation (19/01/2021)
The LuxTopic-Aktien Europa is managed using a well structured investment process focussing on European blue chips which was developed by qualified engineer Robert Beer. Out of the universe of the EURO STOXX 50 the portfolio management selects - by use of a technical momentum stock selection process - rule-based those stocks exhibiting the highest positive momentum. As second essential component of the investment process the management pursues an active option based risk management in order to cushion negative market developments on fund’s performance.
- Growth opportunities of Europe's top global companies
- Stable investment approach, proven in many market phases
- Active risk management using well established options strategy
- Equities may be subject to significant price falls
- Issuer country, credit and liquidity risks
- Price risks of bonds when interest rates rise
Legal Information / Disclaimer:
Figures subject to revision by the auditors on the reporting dates. The published information does not constitute investment advice or a recommendation, but only provides a brief summary of the key features of the fund. The current sales documents (Key Investor Information Document, prospectus, annual report and – if the annual report is older than eight months – the semi-annual report) for the respective investment funds form the sole basis for the purchase of securities. The sales documents are available at no charge at the respective fund company, the distribution company or at www.dje.de. All data and estimates are indicative and may change at any time. This information is based on our assessment of current legal and tax regulations. The data were carefully compiled, but no guarantee can be given for the accuracy of such information. All data are subject to change. The performance is calculated using the BVI (Bundesverband Investment und Asset Management e.V.) method, i.e. without taking into account the subscription fee. Individual expenses such as fees, commissions and other charges are not taken into account in the data and would have a detrimental effect on the performance if they were. The subscription fees payable reduce the invested capital as well as the performance depicted. Data on past performance are not a reliable indicator of future performance. The tax treatment depends on the individual circumstances of the investor and may be subject to change. Please see the prospectus for more detailed tax information. In connection with brokering fund units, the Dr. Jens Ehrhardt Group and its distribution partners may receive reimbursements from costs charged to the funds by the investment companies in accordance with the respective prospectuses. The units of this fund that are issued may only be sold or offered for sale in jurisdictions in which such offer or sale is permitted. Therefore the units of this fund may not be offered for sale or sold in the USA, or offered for sale or sold to or for the account of US citizens or US persons resident in the USA. This document and the information it contains may not be distributed in the USA. The distribution and publication of this document and the offer or sale of units may also be subject to restrictions in other jurisdictions.
*) © 2016 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.